参考文献/References:
[1] DeSantis C, Ma J, Bryan L, et al. Breast cancer statistics, 2013[J]. CA Cancer J Clin, 2014, 64(1):52-62. DOI:10.3322/caac.21203.
[2] Zhou C, He JJ, Li J, et al. A nation-wide multicenter 10-year (1999-2008) retrospective clinical study of endocrine therapy for Chinese females with breast cancer[J/OL]. PLoS One, 2014, 9(7):e100159[2017-01-12]. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0100159. DOI:10.1371/journal.pone.0100159.
[3] Siegel R, Naishadham D, Jemal A. Cancer Statistics[J]. CA Cancer J Clin, 2013, 63(1):11-30. DOI:10.3322/caac.21166.
[4] 贺捷, 陈万青. 2012中国肿瘤登记年报[M]. 北京:军事医学科学出版社, 2012:28. He J, Chen WQ. 2012 Annual Report of Cancer Registry in China[M]. Beijing:Press of Military Medical Sciences, 2012:28.
[5] Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12):2893-2917. DOI:10.1002/ijc.25516.
[6] Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China[J].Lancet Oncol, 2014,15(7):e279-e289. DOI:10.1016/S1470-2045(13)70567-9.
[7] 张敏璐, 黄哲宙, 郑莹. 中国2008年女性乳腺癌发病、死亡和患病情况的估计及预测[J]. 中华流行病学杂志, 2012, 33(10):1049-1051. DOI:10.3760/cma.j.issn.0254-6450.2012.10.012. Zhang ML, Huang ZZ, Zheng Y. Estimates and prediction on incidence, mortality and prevalence of breast cancer in China, 2008[J]. Chin J Epidemiol, 2012, 33(10):1049-1051.
[8] 江泽飞, 陈佳艺, 牛晓辉, 等. 乳腺癌骨转移和骨相关疾病临床诊疗专家共识(2014版)[J]. 中华医学杂志, 2015, 95(4):241-247. DOI:10.3760/cma.j.issn.0376-2491.2015.04.001. Jiang ZF, Chen JY, Niu XH, et al. Expert consensus on clinical diagnosis and treatment of bone metastasis and bone related diseases in breast cancer(2014 edition)[J]. Nat Med J China, 2015, 95(4):241-247.
[9] Lipton A, Cook RJ, Major P, et al. Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity[J]. Oncologist, 2007, 12(9):1035-1043. DOI:10.1634/theoncologist.12-9-1035.
[10] Hirsh V, Major PP, Lipton A, et al. Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity[J]. J Thorac Oncol, 2008, 3(3):228-236. DOI:10.1097/JTO.0b013e3181651c0e.
[11] 于世英. 恶性肿瘤骨转移的诊断与治疗[M]. 北京:中国协和医科大学出版社, 2012:25-35. Yu SY. Diagnosis and treatment of bone metastases in malignant tumor[M]. Beijing:Peking Union Medical College Press, 2012:25-35.
[12] 李林, 赵祯, 郭兴. 恶性肿瘤骨转移影像学诊断[J]. 中华核医学杂志, 2006, 26(5):315-318. DOI:10.3760/cma.j.issn.2095-2848. 2006.05.023. Li L, Zhao Z, Guo X. Malignant tumor imaging in the diagnosis of bone metastases[J]. Chin J Nucl Med, 2006, 26(5):315-318.
[13] 郑飞波, 刘晚霞, 丁月云, 等. 转移性骨肿瘤的影像学诊断进展[J]. 实用医学影像杂志, 2015, 16(3):253-255. DOI:10.16106/j.cnki.cn14-1281/r.2015.03.025. Zheng FB, Liu WX, Ding YY, et al. The progress of imaging diagnosis of metastatic bone tumor[J]. J Pract Med Imaging, 2015, 16(3):253-255.
[14] 邱艳芳, 赵艳萍. 骨转移瘤的影像学诊断研究现状[J]. 海南医学, 2015, 26(4):543-546. DOI:10.3969/j.issn.1003-6350.2015.04. 0196. Qiu YF, Zhao YP. Research status of imaging diagnosis of osseous metastatic tumor[J]. Hainan Med J, 2015, 26(4):543-546.
[15] 齐红艳, 孙逊, 安锐. 骨转移瘤影像学检查方法及相关进展[J]. 华中科技大学学报:医学版, 2015, 44(1):121-124. DOI:10.3870/j.issn.1672-0741.2015.01.025. Qi HY, Sun X, An R. Bone metastases imaging examnination method and the related progress[J]. Acta Med Univ Sci Technol Huazhong, 2015, 44(1):121-124.
[16] 王兵, 董越, 郑邵微, 等. CT能谱成像鉴别诊断肺癌成骨性转移瘤与骨岛的价值[J]. 中国医学影像技术, 2014, 30(10):1552-1556. Wang B, Dong Y, Zheng SW, et al. Spectral CT imaging in differential diagnosis of osteoblastic metastases and bone islands in patients with lung cancer[J]. Chin J Med Imaging Technol, 2014, 30(10):1552-1556.
[17] 胡鸿, 唐刚华, 聂大红. 乳腺癌分子显像研究进展[J]. 国际放射医学核医学杂志, 2015, 39(1):91-95. DOI:10.3760/cma.j.issn.1673-4114. 2015.01.019. Hu H, Tang GH, Nie DH. Progress on molecular imaging of breast cancer[J]. Int J Radiat Med Nucl Med, 2015, 39(1):91-95.
[18] 赵应满, 陈峰, 许琴, 等. MR弥散加权成像骨髓对比率与核素骨显像在脊柱转移瘤诊断中的价值[J]. 中国脊柱脊髓杂志, 2013, 23(9):810-814. DOI:10.3969/j.issn.1004-406X.2013.09.09. Zhao YM, Chen F, Xu Q, et al. Comparison of MR diffusion weighted imaging bone marrow ratio and radionuclide bone imaging in the diagnosis of spine metastasis[J]. Chin J Spine Spinal Cord, 2013, 23(9):810-814.
[19] 王警建, 崔尊社, 李娜. 全身MRI和骨扫描诊断乳腺癌骨转移比较[J]. 湖北医药学院学报, 2011, 30(5):458-460. Wang JJ, Cui ZS, Li N. Comparison of whole-body MRI and bone scintigraphy for diagnosing osseous metastasis in patients with breast cancer[J]. J Hubei Univ Med, 2011, 30(5):458-460.
[20] Gutzeit A, Doert A, Froehlich JM, et al. Comparison of difusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma[J]. Skeletal Radiol, 2010, 39(4):333-343. DOI:10.1007/s00256-009-0789-4.
[21] 孙梦恬, 程敬亮, 张勇, 等. 背景抑制全身扩散加权成像对不同类型骨转移瘤诊断价值的探讨[J]. 临床放射学杂志, 2013, 32(2):236-241. Sun MT, Cheng JL, Zhang Y, et al. The diagnostic value of DWIBS in various types of bone metastasis[J]. J Clin Radiol, 2013, 32(2):236-241.
[22] 汪建强, 曹春晓, 杨琦, 等. 18F-FDG SPECT/CT符合线路显像、99Tcm-MDP骨显像及MRI对脊柱转移瘤诊断效能的对比[J]. 中华核医学与分子影像杂志, 2015, 35(5):403-404. DOI:10.3760/cma.j.issn.2095-2848.2015.05.015. Wang JQ, Cao CX, Yang Q, et al. The comparsion of 18F-FDG SPECT/CT, 99Tcm-MDP bone scan and MRI in the diagnosis of spinal metastases[J]. Chin J Nucl Med Mol Imaging, 2015, 35(5):403-404.
[23] Chakraborty D, Bhattacharya A, Mete UK, et al. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma[J]. Clin Nucl Med,2013, 38(8):616-621. DOI:10.1097/RLU.0b013e31828da5cc.
[24] 董科, 傅健飞, 楼菁菁, 等. 分子影像SPECT/CT对乳腺癌骨转移的临床应用价值[J]. 中国临床医学影像杂志, 2015, 26(7):465-468. Dong K, Fu JF, Lou JJ, et al. The clinical application value of molecular imaging SPECT/CT for bone metastases from breast cancer[J]. J Chin Clin Med Imaging, 2015, 26(7):465-468.
[25] 彭东, 徐可为, 王荣辉, 等. SPECT/CT融合显像诊断肿瘤骨转移的临床价值[J]. 广西医学, 2014, 36(8):1153-1155. DOI:10.11675/j.issn.0253-4304.2014.08.44. Peng D, Xu KW, Wang RH, et al. The value of SPECT/CT fusion imaging in diagnosis of tumor bone metastases[J]. Guangxi Med J, 2014, 36(8):1153-1155.
[26] Schirrmeister H, Guhlmann A, Kotzerke J, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography[J]. J Clin Oncol, 1999, 17(8):2381-2389. DOI:10.1200/JCO.1999. 17.8.2381.
[27] Ohta M, Tokuda Y, Suzuki Y, et al. Whole body PET for the evaluation of bony metastases in patients with breast cancer:comparison with 99Tcm-MDP bone scintigraphy[J]. Nucl Med Commun, 2001, 22(8):875-879. DOI:10.1097/00006231-200108000-00005.
[28] 郭粹, 陈虞梅, 童林军, 等. PET/CT在乳腺癌疗效监测中的作用[J].国际医学放射学杂志, 2016, 39(2):146-150, 161. DOI:10.19300/j.2016.Z3667. Guo C, Chen YM, Tong LJ, et al. The role of PET/CT in monitering the treatment effect of breast cancer[J]. Int J Med Radiol, 2016, 39(2):146-150, 161.
[29] Minamimoto R, Loening A, Jamali M, et al. Prospective comparison of 99mTc-MDP scintigraphy, combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in patients with breast and prostate cancer[J]. J Nucl Med, 2015, 56(12):1862-1868. DOI:10.2967/jnumed.115. 162610.
[30] 辛军, 孙洪赞, 王鹏远, 等. 同机PET/MR显像临床应用价值初探[J]. 中华核医学与分子影像杂志, 2014, 34(6):428-432. DOI:10.3760/cma.j.issn. 2095-2848. 2014.06.003. Xin J, Sun HZ, Wang PY, et al. Preliminary clinical application of hybrid PET/MR[J]. Chin J Nucl Med Mol Imaging, 2014, 34(6):428-432.
相似文献/References:
[1]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
[4]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[5]陈伟君,孙达.99Tcm-MIBI显像在乳腺癌新辅助化疗中的应用价值[J].国际放射医学核医学杂志,2015,39(6):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
Chen Weijun,Sun Da.Clinical value of 99Tcm-MIBI imaging in neoadjuvant chemotherapy of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
[6]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[7]张胤,陈跃.18F-氟化钠PET/CT诊断肿瘤骨转移应用进展[J].国际放射医学核医学杂志,2015,39(1):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
Zhang Yin,Chen Yue.Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
[8]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[9]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[10]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[11]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[12]王宇峰,刘海娜,张居洋,等.SPECT/CT融合显像对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
Wang Yu-feng,Liu Hai-na,Zhang Ju-yang,et al.Clinical value of SPECT/CT fusion imaging in diagnosing metastatic bone lesions in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
[13]樊孝廉,鲁胜男,古炎发,等.乳腺癌患者骨病灶SPECT/CT融合显像的临床价值[J].国际放射医学核医学杂志,2013,37(4):221.[doi:10.3760/cma.j.issn.1673-4114.2013.04.008]
FAN Xiao-lian,LU Sheng-nan,GU Yan-fa,et al.The clinical value of SPECT/CT fusion imaging in the diagnosis of bone metastasis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):221.[doi:10.3760/cma.j.issn.1673-4114.2013.04.008]
[14]袁超,李卫鹏,胡永全,等.89Sr治疗乳腺癌和前列腺癌多发性骨转移的临床观察[J].国际放射医学核医学杂志,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
YUAN Chao,LI Wei-peng,HU Yong-quan,et al.Clinical observation of 89Sr treatment efficacy of multiple bone metastases in breast and prostate cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
[15]路宝士,高玉芳.血清CA15-3、CEA检测联合全身骨显像在乳腺癌骨转移中的诊断价值[J].国际放射医学核医学杂志,2011,35(2):107.[doi:10.3760/cma.j.issn.1673-4114.2011.02.010]
LU Bao-shi,GAO Yu-fang.The value of combined examination of serum CA15-3, CEA level and whole body bone scan in the diagnosis of bone metastasis in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):107.[doi:10.3760/cma.j.issn.1673-4114.2011.02.010]
[16]佟丽娟,王明泽,王丽梅.肺癌、乳腺癌、食道癌远端骨转移特点的对比研究[J].国际放射医学核医学杂志,2011,35(1):38.[doi:10.3760/cma.j.issn.1673-4114.2011.01.011]
TONG Li-juan,WANG Ming-ze,WANG Li-mei.Comparative study between characteristics of the lung cancer, breast cancer and esophageal cancer distal bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):38.[doi:10.3760/cma.j.issn.1673-4114.2011.01.011]
[17]袁超,陶健,袁媛,等.血清CA15-3、CEA及全身骨显像联合检查对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2009,33(6):353.[doi:10.3760/cma.j.issn.1673-4114.2009.06.011]
YUAN Chao,TAO Jian,YUAN Yuan,et al.The diagnostic significance of CA15-3, CEA combined with whole body bone scan for bone metastases in patients with breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(4):353.[doi:10.3760/cma.j.issn.1673-4114.2009.06.011]
[18]张亶,章斌,邓胜明,等.18F-FDG PET/CT在乳腺癌术后随访中的价值[J].国际放射医学核医学杂志,2017,41(3):159.[doi:10.3760/cma.j.issn.1673-4114.2017.03.001]
Zhang Dan,Zhang Bin,Deng Shengming,et al.Clinical value of 18F-FDG PET/CT in follow-up of postoperative breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(4):159.[doi:10.3760/cma.j.issn.1673-4114.2017.03.001]